Biden brings back Obama-era staff for COVID-19 response team

18 January 2021

Incoming US President Joe Biden - due to be sworn in on Wednesday - has outlined several new appointments to the team in charge of tackling the coronavirus pandemic in the USA.

Former Food and Drug Administration Commissioner David Kessler will take up the role of chief science officer, sharing responsibility for Operation Warp Speed with current chief operating officer Gustave Perna.

Mr Biden, who has described the vaccine rollout program as a “dismal failure,” has pledged to deliver 100 million vaccinations in the country within his first 100 days in the White House.

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK